join us
CN
Home page
About Us
Profile
Affiliates/Subsidiaries
Development History
Quality Management
Contact Us
Legal Statement
Adverse Reaction Report
Science and Technology
R&D platform
R&D pipeline
Therapeutic Field
International Business
APIs
Finished Products
Medical device
Download product list
Contact
News Center
News & Trends
Public information
Learn latest news of our company
follow developments of our company
News & Trends
04
2025-06
Breaking News! China’s First ARB + Thiazide-like D...
28
2025-05
Salubris Obtains Exclusive License for Small Inter...
27
2025-05
Blockbuster! China's First Domestically Devel...
30
2025-04
Salubris' Novel Hypertension Drug SAL0140 Gai...
17
2025-04
Salubris' PCSK9 base-editing drug YOLT-101 ha...
Learn more News & Trends